title: Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene.
abstract: Cardiovascular abnormalities represent the major cause of death in patients with acromegaly. We evaluated cardiac structure, function, and energy status in adult transgenic mice overexpressing bovine GH (bGH) gene. Female transgenic mice expressing bGH gene (n = 11) 8 months old and aged matched controls (n = 11) were used. They were studied with two-dimensional guided M-mode and Doppler echocardiography. The animals (n = 6) for each group were examined with 31P magnetic resonance spectroscopy to determine the cardiac energy status. Transgenic mice had a significantly higher body weight (BW), 53.2+/-2.4 vs. 34.6+/-3.7 g (P < 0.0001) and hypertrophy of left ventricle (LV) compared with normal controls: LV mass/BW 5.6+/-1.6 vs. 2.7+/-0.2 mg/g, P < 0.01. Several indexes of systolic function were depressed in transgenic animals compared with controls mice such as shortening fraction 25+/-3.0% vs. 39.9+/-3.1%; ejection fraction, 57+/-9 vs. 77+/-5; mean velocity of circumferential shortening, 4.5+/-0.8 vs. 7.0+/-1.1 circ/sec, p < 0.01. Creatine phosphate-to-ATP ratio was significantly lower in bGH overexpressing mice (1.3+/-0.08 vs. 2.1+/-0.23 in controls, P < 0.05). Ultrastructural examination of the hearts from transgenic mice revealed substantial changes of mitochondria. This study provides new insight into possible mechanisms behind the deteriorating effects of long exposure to high level of GH on heart function.
authors.affiliation: Wallenberg and Lundberg Laboratories, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Bollano
authors.forename: E
authors.initials: E
authors.lastname: Omerovic
authors.forename: M
authors.initials: M
authors.lastname: Bohlooly-y
authors.forename: V
authors.initials: V
authors.lastname: Kujacic
authors.forename: B
authors.initials: B
authors.lastname: Madhu
authors.forename: J
authors.initials: J
authors.lastname: Törnell
authors.forename: O
authors.initials: O
authors.lastname: Isaksson
authors.forename: B
authors.initials: B
authors.lastname: Soussi
authors.forename: W
authors.initials: W
authors.lastname: Schulze
authors.forename: M L
authors.initials: ML
authors.lastname: Fu
authors.forename: G
authors.initials: G
authors.lastname: Matejka
authors.forename: F
authors.initials: F
authors.lastname: Waagstein
authors.forename: J
authors.initials: J
authors.lastname: Isgaard
mesh_terms: D000172:Acromegaly / Q000150:complications; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D002417:Cattle; D004452:Echocardiography; D004734:Energy Metabolism; D005260:Female; D015870:Gene Expression; D013006:Growth Hormone / Q000235:genetics* / Q000502:physiology; D006331:Heart Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008822:Mice, Transgenic; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D009929:Organ Size; D010725:Phosphocreatine / Q000378:metabolism; D013599:Systole
chemical_list: D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D013006:Growth Hormone